Annual Drug Patent Expirations for TECHNIVIE
Technivie is a drug marketed by Abbvie Inc and is included in one NDA. There are nine patents protecting this drug.
Drug patent litigation for TECHNIVIE.
This drug has three hundred and thirty-four patent family members in forty-five countries.
The generic ingredient in TECHNIVIE is ombitasvir; paritaprevir; ritonavir. Additional details are available on the ombitasvir; paritaprevir; ritonavir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com